Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
06/08/2024 07:55
Aug 6 (Reuters) - Amniotics AB (publ) AMNI.ST :
* AMNIOTICS APPLIES FOR DELISTING FROM NASDAQ FIRST NORTH
GROWTH
MARKET CONDITIONAL UPON COMPLETION OF THE MERGER WITH MAGLE
GROUP
* PROPOSES LAST DAY OF TRADING SHALL BE SEPT 27
Source text for Eikon: ID:nMFN3MDLmF
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan